PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Viral Immunology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.\', \'Department of Biotechnology, Institut für Biochemie, Biotechnologie und Bioinformatik, Technischen Universität Braunschweig, Braunschweig, Germany.\', \'Oxford Vaccine Group, University of Oxford, Oxford, UK.\', \'Center for Proteomics, University of Rijeka, Faculty of Medicine, Rijeka, Croatia.\', \'Infection Biology Unit, German Primate Center, Göttingen, Germany.\', \'Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.\', \'Department of Immunology, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.\', \'Infection Immunology, Institute for Medical Microbiology and Hospital Hygiene, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany; Immune Regulation, Helmholtz Centre for Infection Research, Braunschweig, Germany.\', \'Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.\', \'Institute of Virology, Medical University Münster, Münster, Germany.\', \'Institute of Virology, Hannover Medical School (MHH), Hannover, Germany.\', \'Department of Viral Immunology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany. luka.cicin-sain@helmholtz-hzi.de.\', \'German Centre for Infection Research (DZIF), Hannover-Braunschweig Site, Hannover, Germany. luka.cicin-sain@helmholtz-hzi.de.\', \'Centre for Individualized Infection medicine (CiiM), a joint venture of HZI and MHH, Hannover, Germany. luka.cicin-sain@helmholtz-hzi.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41423-021-00814-5
?:hasPublicationType
?:journal
  • Cellular & molecular immunology
is ?:pmid of
?:pmid
?:pmid
  • 34992275
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34992275>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34992275>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all